| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―May―12 |
Insulin Resistance as the Basis for the Comorbidity Development in Convalescents after COVID-19 and Patients With Chronic Obstructive Pulmonary Disease (COPD): Peculiarities of Manifestations and Changes under the Influence of Recovery Treatment |
O.I. Lemko, N.V. Vantiukh, D.V. Reshetar |
| 2 |
[GO] |
2026―Mar―27 |
Post-COVID Syndrome (Long COVID): Possible Causes of Development |
I.S. Markov, A.I. Markov, S.O. Kramarov, I.Yu. Seriakova |
| 3 |
[GO] |
2026―Mar―27 |
Myocardiofibrosis in Convalescents after Coronavirus Infection (Clinical Case) |
I.D. Duzhyi, L.N. Prystupa, O.V. Kravets, I.A. Danylenko, A.D. Klochko, R.Z. Elastal |
| 4 |
[GO] |
2025―Oct―30 |
Directions of Optimizing Antibiotic Therapy of Elderly Patients with Coronavirus Disease |
O.A. Golubovska, O.V. Bezrodna, D.V. Turchak |
| 5 |
[GO] |
2025―Oct―30 |
Stratification of Patient Groups Depending on the Course of COVID-19 Taking into Account the Levels of Interleukins-10 and -6 and their Ratio |
K.Yu. Lytvyn, O.O. Bilokon, O.A. Kushnierova, I.O. Gubar, O.O. Volicova |
| 6 |
[GO] |
2025―Jul―29 |
Criteria for Distinguishing Pulmonary Tuberculosis from Community-Acquired Pneumonia of Moderate to Severe Course and Associated with COVID-19. Part 1 |
E.V. Lesnic, L.D. Todoriko |
| 7 |
[GO] |
2025―Jul―29 |
Prognostic Value of the Lipocalin Marker in Children with COVID-19 |
V.V. Yevtushenko, I.Yu. Seriakova, S.O. Kramarov |
| 8 |
[GO] |
2025―May―29 |
Peculiarities of the Development of Frederick’s Syndrome as a Marker of the Severe Course of Coronavirus Disease |
I.D. Duzhyi, V.Ya. Pak, A.D. Klochko, L.A. Bondarenko, R.Z. Elastal |
| 9 |
[GO] |
2025―May―29 |
The Impact of the Reorganisation of the Phthisiology Service During the Coronavirus Infection (COVID-19) Epidemic and Russia’s Full-Scale Military Aggression Against Ukraine on the Development of Tuberculosis Relapses in North-Eastern Slobozhanshchyna (Review) |
I.D. Duzhyi, L.N. Prystupa, O.V. Kravets |
| 10 |
[GO] |
2025―May―29 |
Pathogenetic and Pathomorphological Aspects of Pulmonary Tissue Damage in COVID-19 as a Manifestation of Vasculitis |
A.A. Nevzghoda, O.A. Nevzghoda, M.R. Semko |
| 11 |
[GO] |
2025―Feb―05 |
Analysis of Comorbidities in Hospitalized Patients with Coronavirus Disease 2019 |
O.V. Riaba, O.A. Golubovska |
| 12 |
[GO] |
2025―Feb―05 |
The Impact of Cardiovascular Risk Factors on the Quality of Life of Patients with Community-Acquired Pneumonia Associated with COVID-19 |
I.V. Chaban, M.I. Marushchak |
| 13 |
[GO] |
2024―Dec―12 |
Characteristics of The Development of the COVID-19 Pandemic in Ukraine and Peculiarities of Epidemiologic Surveillance |
V.V. Korolenko, H.A. Mokhort, T.V. Petrusevych, V.V. Korolenko |
| 14 |
[GO] |
2024―Dec―12 |
Impact of the COVID-19 Pandemic and Martial Law on the Dynamics of Tuberculosis in Sumy Region |
I.D. Duzhyi, V.V. Hlynenko, P.F. Myronov, O.Ye. Biehouliev |
| 15 |
[GO] |
2024―Dec―12 |
The Impact of the Risk Factors on Generalisation of Tuberculosis Infection During COVID-19 Pandemic |
E. Lesnic, L.D. Todoriko, I.O. Semianiv, A. Niguleanu |
| 16 |
[GO] |
2024―Dec―12 |
The Expression Levels of HIF-1a and the Long Non-Coding RNA HIF1A-AS1 in the Buffy Coat as Prognostic Markers for Severe COVID-19 Outcomes in Patients with Diabetes and Obesity |
E.I. Dubrovskyi, T.I. Drevytska, A.G. Portnychenko, V.Ye. Dosenko |
| 17 |
[GO] |
2024―Dec―12 |
Screening for and Treatment of Epstein-Barr Virus Infection Reactivation as Rehabilitation Tool in Uncontrolled Asthma Patients Who Have Had COVID-19 |
Y.I. Feshchenko, M.O. Polianska, V.I. Ignatieva, G.L. Gumeniuk, S.G. Opimakh |
| 18 |
[GO] |
2024―Oct―15 |
Особливості гранулоцитарно-лімфоцитарного співвідношення у хворих на туберкульоз легень після COVID-19 |
Ю.О. Матвієнко, О.М. Рекалова, О.Р. Панасюкова, В.М. Жадан, С.Г. Ясирь, А.В. Тараненко, М.П. Будьонна |
| 19 |
[GO] |
2024―Sep―25 |
Impact of Comorbid Pathology and Severity of Clinical Course on Anti-infective Protection in Patients with COVID-19 |
M.O. Sokolenko |
| 20 |
[GO] |
2024―Sep―25 |
Pathomorphological Changes of the Placenta in Antenatal Asphyxia of the Fetus Associated with the Coronavirus Disease (COVID-19) in Pregnant Women |
T.V. Savchuk |
| 21 |
[GO] |
2024―Sep―25 |
Contemporary Concepts of the Role of Pro-inflammatory Cytokines in COVID-19-Induced Pneumonia in the Context of Metabolic Disorders (Review) |
R.B. Aliiev, A.S. Shapovalova, S.I. Abuwatfa |
| 22 |
[GO] |
2024―May―29 |
The Role of Microbiological and Radiological Tests in the Diagnosis of Pulmonary Tuberculosis in the Conditions of the Pandemic COVID-19 |
E. Lesnic, L.D. Todoriko, I.V. Yeremenchuk, O.S. Shevchenko, V.I. Slyvka |
| 23 |
[GO] |
2024―Mar―04 |
Differential Diagnostics of the Disappearing Lung Syndrome in Lymphangioleiomyomatosis and COVID-19 Pneumonia Using Digital Software Processing of Computer Tomography Data (Clinical Cases) |
М.І. Lynnyk, І.V. Liskina, V.І. Іgnatieva, G.L. Gumeniuk, V.А. Svyatnenko, O.P. Chobotar, O.K. Yakovenko |
| 24 |
[GO] |
2024―Mar―04 |
Evaluation of the Level of Serum Interleukin-10 Depending on the Demographic and General Clinical and Laboratory Characteristics of the Coronavirus Disease-19 in Hospitalized Patients |
O.O. Bilokon, K.Yu. Lytvyn |
| 25 |
[GO] |
2024―Mar―04 |
The Influence of Coronavirus Infection on the Results of Percutaneous Coronary Intervention in Patients with Coronary Artery Disease |
G.B. Mankovsky, M.V. Kucheriava |
| 26 |
[GO] |
2023―Dec―08 |
COVID-19 and Myasthenia Gravis Exacerbation in an Elderly Patient: a Case Report |
I.P. Kaidashev, A.V. Lavrenko, Ya.M. Avramenko, L.P. Ozarchuk |
| 27 |
[GO] |
2023―Dec―08 |
Community-Acquired Pneumonia Associated with COVID-19: Diagnostic Significance of Imaging Methods (CT, LUS) and Comparative Characteristics of CT- and LUS-Patterns |
L.І. Konopkina, К.V. Rybalka |
| 28 |
[GO] |
2023―Sep―29 |
The Value of NSE, S100, and E-Selectin Biomarkers for Predicting the Course and Severity of COVID-19 in Children |
I.Yu. Seriakova, S.O. Kramarov, V.V. Yevtushenko, L.O. Palatna, I.V. Shpak, O.O. Voronov, et al. (+2) V.O. Doroshenko, M.O. Dudnikova |
| 29 |
[GO] |
2023―Sep―29 |
Dynamics of the Main Indicators of Tuberculosis Epidemiology in Bukovina, the Influence of the COVID-19 Pandemic and Wartime Conditions |
L.D. Todoriko, Ya.I. Toderika, I.I. Huska, N.O. Karnas |
| 30 |
[GO] |
2023―Jun―23 |
Ways of transformation of typical X-ray signs of community acquired pneumonia of viral etiology (COVID-19) according to radiomics data |
М.І. Lynnyk, V.І. Іgnatieva, G.L. Gumeniuk, O.K. Yakovenko, V.А. Svyatnenko |
| 31 |
[GO] |
2023―Jun―23 |
Distance learning in the context of the COVID-19 pandemic and war in Ukraine according to medical university students |
Z.I. Piskur, O.P. Kostyk, U.B. Chulovska, N.M. Halyshych, O.I. Sahelashvili-Bil |
| 32 |
[GO] |
2023―Jun―23 |
Markers of quality of life in patients with nosocomial pneumonia caused by SARS-CoV-2 |
T.M. Homeliuk, M.I. Marushchak |
| 33 |
[GO] |
2023―Mar―29 |
Risk factors for in-hospital mortality in patients with COVID-19 |
O.O. Bilokon, K.Yu. Lytvyn |
| 34 |
[GO] |
2023―Mar―29 |
The dynamics of incidence of active tuberculosis in children in Bukovina, the impact of the COVID-19 pandemic |
L.D. Todoriko |
| 35 |
[GO] |
2022―Dec―28 |
Tuberculosis in Ukraine during the COVID-19 pandemic |
Yu.M. Valetskyi, R.O. Valetska, L.A. Hryshchuk, V.M. Zahorulko, L.Ya. Patrakeieva, S.M. Pakharchuk |
| 36 |
[GO] |
2022―Dec―28 |
The role of melatonin in the formation of tuberculotic inflammation, forecast regarding the influence on the effectiveness of treatment in the conditions of the COVID-19 pandemic (literature review) |
L.D. Todoriko, Ya.I. Toderika |
| 37 |
[GO] |
2022―Sep―30 |
Features of the long-term course of community-acquired viral pneumonia COVID-19 according to computed tomography (clinical cases) |
O.K. Yakovenko, М.I. Lynnyk, V.I. Іgnatieva, V.A. Svyatnenko, V.V. Polischuk |
| 38 |
[GO] |
2022―Sep―30 |
Recurrence of bilateral polysegmental pneumonia associated with COVID-19 (clinical case) |
L.A. Hryshchuk, N.M. Lopushanska |
| 39 |
[GO] |
2022―Jun―24 |
The course of pregnancy and relapse of tuberculosis after COVID-19 |
О.М. Raznatovska, O.S. Shalmin, V.G. Syusyuka, Yu.V. Mironchuk, A.V. Fedorec, O.A. Svitlytska |
| 40 |
[GO] |
2022―Jun―24 |
Remote results of the course of non-acute viral pneumonia COVID-19 according to computed tomography |
O.K. Yakovenko, M.I. Linnik, V.I. Ignatieva, G.L. Gumenyuk, O.R. Tarasenko, V.A. Svyatinenko |
| 41 |
[GO] |
2021―Dec―17 |
Epidemiological trends in tuberculosis in Ukraine at the beginning of the COVID-19 pandemic |
Yu.M. Valetskyi, R.O. Valetska, L.A. Hryshchuk, M.I. Sakhelashvili, V.M. Zahorulko, K.D. Mazhak, et al. (+2) S.M. Pakharchuk, L.Ya. Patrakeieva |
| 42 |
[GO] |
2021―Jul―02 |
Coronavirus disease (COVID19): a review |
R.G. Protsyuk |
| 43 |
[GO] |
2021―Jul―02 |
Antituberculosis in the minds of the pandemic caused by the coronavirus SARSCoV2 (on the results of the hearings in the Committee of the Verkhovna Rada of Ukraine on the health of the nation, medical care and health insurance) |
L.A. Masiuk, О.V. Vasilenko, E.P. Gelіukh, Z.М. Islam |
| 44 |
[GO] |
2021―Mar―24 |
Problem issues of the pathogenesis of inflammatory reaction and the course of coronavirus infection |
L.D. Todoriko |
| 45 |
[GO] |
2020―Nov―26 |
Features of tuberculosis in a COVID-19 pandemic |
L.D. Todoriko, M.M. Ostrovskyi, I.O. Semianiv, O.S. Shevchenko |
| 46 |
[GO] |
2020―Nov―24 |
Challenges and benefits of integrating online learning in higher education in a pandemicof COVID-19 |
O.S. Shevchenko, L.D. Todoriko, V.I. Petrenko, R.S. Shevchenko, I.A. Ovcharenko, O.O. Pohorielova |
| 47 |
[GO] |
2020―Nov―24 |
Distance learning as an alternative to continuing educationin the context of the COVID-19 pandemic |
L.D. Todoriko, I.O. Semianiv, O.V. Pidverbetska, I.V. Yeremenchuk, V.I. Slivka, O.Ya. Podverbetskiy |
| 48 |
[GO] |
2020―Sep―09 |
Thoracic cavity visualization as a part of a diagnostic examination for patients with suspected COVID-19 |
V.I. Petrenko, S.B. Noreiko, Yu.O. Hrechaniuk, Ya.V. Bondarenko |
| 49 |
[GO] |
2020―Jun―23 |
COVID-19 - а new viral infection: pathogenesis, diagnostics, treatment |
О.M. Rekalova |
| 50 |
[GO] |
2020―Jun―23 |
Features of the clinical course, diagnosis and treatment of pneumonia caused by SARS-CoV-2 |
V.I. Petrenko, S.B. Noreiko, T.V. Mostepan, H.V. Aksiutin, L.I. Popova, Yu.O. Patiuk, et al. (+3) M.V. Gamachek, Yu.O. Hrechaniuk, Ya.V. Bondarenko |
